{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-007073","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.098397+00:00","generated_at":"2026-06-08T03:22:48.162731+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Predictive Oncology narrows Q3 net loss 22% to $3.2M; revenue rises 57% to $715K","bullets":["Net loss of $3.2M ($0.78 per share) vs $4.1M ($1.04) in Q3 2022, a 22% reduction.","Revenue of $715,056, up 57% YoY, driven by higher sales of 3-D models.","Gross margin improved to 85% from 76%; G&A expenses decreased $704K to $2.58M.","Cash and equivalents $11.9M (down from $22.1M at Dec 31, 2022); equity $11.7M.","Milestone: accurately predicted cancer types responsive to CRH's glutaminase inhibitors; ovarian cancer study with UPMC."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-007073","json":"https://secwatch.observer/filing/0001171843-23-007073.json","markdown":"https://secwatch.observer/filing/0001171843-23-007073.md","text":"https://secwatch.observer/filing/0001171843-23-007073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/0001171843-23-007073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/f8k_111323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:22:48.162731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91f4b799af6a23ad641f0393e558405f6bd9e3c6","claim":"Axe Compute Inc. reported three months ended September 30, 2023 results: revenue $715,056, EPS $0.78.","evidence_excerpt":"Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/0001171843-23-007073-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended September 30, 2023"},{"label":"Revenue","value":"$715,056"},{"label":"EPS","value":"$0.78"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}